Clinical trial protocol writing | Pepgra
In brief:
·
A clinical study protocol should provide a transparent clinical study
design to satisfy the target of the clinical test
·
A defined protocol must address the proposed medical
question and protect the security and rights of the clinical test
participant/patients
Clinical trial protocol writing Services |
General
guidelines in writing the clinical protocol:
1.Introduction:
The
introduction must have detailed literature
review covering the prevailing therapeutic options and test methods.
This
section should present the scientific rationale of the clinical test and
identifying the first purpose includes the aim to realize and therefore the
importance of the clinical study.
2.Objective:
This
section should state the target within the form “SMART”. For a transparent
delivery of the target , our experts divide it into a primary, secondary and
exploratory category. during which the first will deliver the aims to answer
clinical test purpose directly, and secondary will explain the associated
actions with the rationale. Finally, the exploratory will state the
hypothesis-generating objectives which will be analysed with additional
studies.
3.Population:
Every
clinical test protocol should define the targeted
population who are going to be used for the trial includes the countryside
and an in depth list of inclusion and exclusion criteria which specifies age,
sex, BMI and medical conditions.
4.Endpoints:
It
is defined as an indicator in measuring a biological sample (in this case
patient) to assess effectiveness and safety or side effects. altogether cases,
there should be an endpoint which exactly matches the target of the study to
make sure that the right variables are measured. during a clinical test study,
variables are parameters which include safety, clinical efficacy, treatment,
age, sex, BMI, smoking history, and health outcomes.
5.Trial design:
The
clinical
test design will indicate the participant’s treatment and therefore the
number of required groups for treatment and data
collections. If the proposed trial is for the second or third phase, the
trial should briefly describe the only group design, which explains the
variables comparing the first phase participants with the exposure to the test
treatment. The trial design also must make sure the presence of bias
minimization. If randomization or blinding aren't utilized in the comparative
trial, then bias minimization techniques should be justified within the
clinical protocol.
6.Control groups:
In
the clinical test protocol, this section explains the control groups and
therefore the target population should be clearly identified and justified, and
therefore the control group must be aligned with the clinical test design and
objective. Besides, all the experimental tests, including placebo, must be
clearly characterized and identified within the clinical test protocol.
7.Statistical
considerations:
This
section within the protocol should explain the rationale for the calculated
sample size with the clinical
Biostatistics services and statistical assumptions supported the first
endpoint and therefore the statistical analysis must present the entire details
of summaries for all endpoints along side the small print of the statistical
analysis plan. To tackle all the complexity in writing a clinical
protocol statistical consideration, we offer statistician support, and when
applicable we provide other support, and that we have experts like
pharmacodynamics/pharmacokinetics experts, quality of life expert, and clinical
writing expert.
Comments
Post a Comment